EcoDrugPlus

Ensembl ID : ENSATEG00000011552
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSATEG00000003568
Gene Symbol: -
Cross references: -
233 Possible Orthologues:

Ensembl ID : ENSATEG00000015123
Gene Symbol: -
Cross references: -
385 Possible Orthologues:

Ensembl ID : ENSATEG00000015085
Gene Symbol: -
Cross references: -
301 Possible Orthologues:

Ensembl ID : ENSATEG00000010873
Gene Symbol: -
Cross references: -
227 Possible Orthologues:

Ensembl ID : ENSATEG00000010693
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSATEG00000003394
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSATEG00000008585
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSATEG00000009811
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSATEG00000007491
Gene Symbol: -
Cross references: -
257 Possible Orthologues:

Ensembl ID : ENSATEG00000019140
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSATEG00000009022
Gene Symbol: -
Cross references: -
193 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).